Tema Neuroscience and Mental Health ETF (NASDAQ:MNTL – Get Free Report) was the target of a significant decline in short interest during the month of January. As of January 31st, there was short interest totalling 200 shares, a decline of 33.3% from the January 15th total of 300 shares. Based on an average daily volume of 400 shares, the days-to-cover ratio is currently 0.5 days.
Tema Neuroscience and Mental Health ETF Stock Down 0.0 %
Shares of MNTL traded down $0.00 during trading hours on Friday, reaching $25.18. 142 shares of the company traded hands, compared to its average volume of 188. Tema Neuroscience and Mental Health ETF has a 12-month low of $23.67 and a 12-month high of $27.66. The stock has a market capitalization of $11.08 million, a P/E ratio of 25.24 and a beta of 0.99. The business has a fifty day moving average price of $25.04 and a 200-day moving average price of $26.01.
Tema Neuroscience and Mental Health ETF Dividend Announcement
The firm also recently declared a dividend, which was paid on Thursday, December 12th. Shareholders of record on Wednesday, December 11th were issued a $0.257 dividend. The ex-dividend date was Wednesday, December 11th.
Tema Neuroscience and Mental Health ETF Company Profile
The Tema Neuroscience and Mental Health ETF (MNTL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, concentrating on companies engaged in addressing disorders of the central nervous system and mental health worldwide. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.
Read More
- Five stocks we like better than Tema Neuroscience and Mental Health ETF
- 3 Healthcare Dividend Stocks to Buy
- Symbotic Shares Down 37%—Is It Time for Bravery or Caution?
- What is a Secondary Public Offering? What Investors Need to Know
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- Investing In Preferred Stock vs. Common Stock
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Receive News & Ratings for Tema Neuroscience and Mental Health ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tema Neuroscience and Mental Health ETF and related companies with MarketBeat.com's FREE daily email newsletter.